Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03356223
Title Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6 (ABORL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications

hypopharynx cancer

oral squamous cell carcinoma

laryngeal squamous cell carcinoma

oropharynx cancer

head and neck squamous cell carcinoma

Therapies

Abemaciclib

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST